3,4-Diaminopyridine

Results: 6



#Item
1Clinical Commissioning Policy Statement: Amifampridine (Firdapse) for Lambert Easton Myasthenic Syndrome (LEMS) April 2013

Clinical Commissioning Policy Statement: Amifampridine (Firdapse) for Lambert Easton Myasthenic Syndrome (LEMS) April 2013

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2014-08-12 08:05:40
2

PDF Document

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2013-08-13 12:09:51
3Contacts: Investors Traci McCarty BioMarin Pharmaceutical Inc[removed]

Contacts: Investors Traci McCarty BioMarin Pharmaceutical Inc[removed]

Add to Reading List

Source URL: files.shareholder.com

Language: English
42,6-Diaminopyridine[removed]OVERVIEW This material was prepared for the National Cancer Institute (NCI) for consideration by the Chemical Selection Working Group (CSWG) by Technical Resources International, Inc. under c

2,6-Diaminopyridine[removed]OVERVIEW This material was prepared for the National Cancer Institute (NCI) for consideration by the Chemical Selection Working Group (CSWG) by Technical Resources International, Inc. under c

Add to Reading List

Source URL: ntp.niehs.nih.gov

Language: English - Date: 2014-11-11 12:59:39
5Final Minutes May 6 and 7, 1999 – 2nd Meeting of the Pharmacy Compounding Advisory Committee Food and Drug Administration Center for Drug Evaluation and Research Advisory Committee Conference Room, Room 1092

Final Minutes May 6 and 7, 1999 – 2nd Meeting of the Pharmacy Compounding Advisory Committee Food and Drug Administration Center for Drug Evaluation and Research Advisory Committee Conference Room, Room 1092

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2001-10-16 14:37:06
6European Medicines Agency Evaluation of Medicines for Human Use

European Medicines Agency Evaluation of Medicines for Human Use

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-07-21 05:57:46